The association of circulating inflammatory and oxidative stress biomarker levels with diagonal earlobe crease in patients with atherosclerotic diseases

Journal of Cardiology

Volumn 67, Issue 4, 2016, Pages 347-351

  Koyama, Takashi ^a   Watanabe, Hiroyuki ^a   Ito, Hiroshi ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Earlobe crease; High sensitivity C reactive protein; Inflammatory response; Malondialdehyde low density lipoprotein; Oxidative stress; Pentraxin3

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; ORAL ANTIDIABETIC AGENT; PENTRAXIN 3; MALONDIALDEHYDE-LOW DENSITY LIPOPROTEIN, HUMAN;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; EAR LOBE; EARLOBE CREASE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; PREVALENCE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; VASCULITIS; ABNORMALITIES; AGED; ANALOGS AND DERIVATIVES; ATHEROSCLEROSIS; BLOOD; COMPLICATION; EXTERNAL EAR; INFLAMMATION; RISK FACTOR;

AGED; ATHEROSCLEROSIS; BIOMARKERS; C-REACTIVE PROTEIN; EAR, EXTERNAL; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PREVALENCE; RISK FACTORS;

EID: 84958861435     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2015.06.002     Document Type: Article

References (19)

1. Lichstein E., Chadda K.D., Naik D., Gupta P.K. Diagonal ear-lobe crease: prevalence and implications as a coronary risk factor. N Engl J Med 1974, 290:615-616.
2. Frank S.T. Aural sign of coronary-artery disease. N Engl J Med 1973, 289:327-328.
3. Shrestha I., Ohtsuki T., Takahashi T., Nomura E., Kohriyama T., Matsumoto M. Diagonal ear-lobe crease is correlated with atherosclerotic changes in carotid arteries. Circ J 2009, 73:1945-1949.
4. Celik S., Erdoğan T., Gedikli O., Kiriş A., Erem C. Diagonal ear-lobe crease is associated with carotid intima-media thickness in subjects free of clinical cardiovascular disease. Atherosclerosis 2007, 192:428-431.
5. Schlager O., Exner M., Mlekusch W., Sabeti S., Amighi J., Dick P., Wagner O., Koppensteiner R., Minar E., Schillinger M. C-reactive protein predicts future cardiovascular events in patients with carotid stenosis. Stroke 2007, 38:1263-1268.
6. Arroyo-Espliguero R., Avanzas P., Quiles J., Kaski J.C. Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease. Atherosclerosis 2009, 204:239-243.
7. Rolph M.S., Zimmer S., Bottazzi B., Garlanda C., Mantovani A., Hansson G.K. Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2002, 22:e10-e14.
8. Lopes-Virella M.F., Hunt K.J., Baker N.L., Lachin J., Nathan D.M., Virella G. Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes. Diabetes 2011, 60:582-589. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.
9. Tani S., Watanabe I., Anazawa T., Kawamata H., Tachibana E., Furukawa K., Sato Y., Nagao K., Kanmatsuse K., Kushiro T. Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound. Am J Cardiol 2005, 96:1089-1094. Surugadai Atherosclerosis Regression Investigators.
10. Tanabe K., Kawai Y., Kitayama M., Akao H., Ishida R., Motoyama A., Wakasa M., Saito R., Aoki H., Fujibayashi K., Watanabe M., Tsuchiya T., Kimura H., Yoshida K., Kajinami K. Increased levels of the oxidative stress marker, nitrotyrosine in patients with provocation test-induced coronary vasospasm. J Cardiol 2014, 64:86-90.
11. Cassar A., Poldermans D., Rihal C.S., Gersh B.J. The management of combined coronary artery disease and peripheral vascular disease. Eur Heart J 2010, 31:1565-1572.
12. Napoleone E., Di Santo A., Bastone A., Peri G., Mantovani A., de Gaetano G., Donati M.B., Lorenzet R. Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. Arterioscler Thromb Vasc Biol 2002, 22:782-787.
13. Peri G., Introna M., Corradi D., Iacuitti G., Signorini S., Avanzini F., Pizzetti F., Maggioni A.P., Moccetti T., Metra M., Cas L.D., Ghezzi P., Sipe J.D., Re G., Olivetti G., et al. PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 2000, 102:636-641.
14. Mak S., Newton G.E. The oxidative stress hypothesis of congestive heart failure: radical thoughts. Chest 2001, 120:2035-2046.
15. Lichtstein E., Chapman I., Gupta P.K., Chadda K.D., Smith H., Schwartz I., Naik D. Letter: diagonal ear-lobe crease and coronary artery sclerosis. Ann Intern Med 1976, 85:337-338.
16. Shoenfeld Y., Mor R., Weinberger A., Avidor I., Pinkhas J. Diagonal earlobe crease and coronary risk factors. J Am Geriatr Soc 1980, 28:184-187.
17. Hofmann B., Adam A.C., Jacobs K., Riemer M., Erbs C., Bushnaq H., Simm A., Silber R.E., Santos A.N. Advanced glycation end product associated skin autofluorescence: a mirror of vascular function?. Exp Gerontol 2013, 48:38-44.
18. Higuchi Y., Maeda T., Guan J.Z., Oyama J., Sugano M., Makino N. Diagonal earlobe crease are associated with shorter telomere in male Japanese patients with metabolic syndrome - a pilot study. Circ J 2009, 73:274-279.
19. Wilson W.R., Herbert K.E., Mistry Y., Stevens S.E., Patel H.R., Hastings R.A., Thompson M.M., Williams B. Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. Eur Heart J 2008, 29:2689-2694.